2012 Drug Safety Communications
- Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves 12/19/2012
- Serious skin reactions after combination treatment with the Hepatitis C drug Incivek (telaprevir), peginterferon alfa, and ribavirin 12/19/2012
- Warning against use of Xyrem (sodium oxybate) with alcohol or drugs causing respiratory depression 12/17/2012
- Safety review update of Chantix (varenicline) and risk of cardiovascular adverse events 12/12/2012
- Important change to heparin container labels to clearly state the total drug strength 12/06/2012
- Updated information on 32 mg intravenous ondansetron (Zofran) dose and pre-mixed ondansetron products 12/04/2012
- Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays 10/25/2012
- Ongoing safety review of Parkinson's drug Mirapex (pramipexole) and possible risk of heart failure 09/12/2012
- Rare cases of serious burns with the use of over-the-counter topical muscle and joint pain relievers 09/13/2012
- FDA recommends against use of Revatio in children with pulmonary hypertension 08/30/2012
- Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine) 07/23/2012
- New information regarding QT prolongation with ondansetron (Zofran) 06/29/2012
- Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment 06/26/2012
- Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod) 05/14/2012
- Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies 05/07/2012
- Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs 04/26/2012
- New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna) 04/20/2012
- Updated information about the risk of blood clots in women taking birth control pills containing drospirenone 04/10/2012
- Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses 03/28/2012
- Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury 03/01/2012
- Important safety label changes to cholesterol-lowering statin drugs 02/28/2012
- CardioGen-82 - Planned return of CardioGen-82 to market with new Boxed Warning 02/15/2012
- Proton Pump Inhibitors - Clostridum difficile -associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs) 02/08/2012
- Tysabri - New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab) 01/20/2012
- Adcetris - New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin) 01/13/2012
- CardioGen-82 - Update: Preliminary findings from ongoing investigations of CardioGen-82 01/12/2012